|Neurology | Clinical Neurosciences | School of Medicine | University of Utah Health Care|
The University of Utah
Center for Alzheimer's Care,
Imaging and Research (CACIR)
Memory Study Line
Tel (801) 587-7888
Cognitive Disorders Clinic
Tel (801) 585-7575
Fax (801) 585-2746
Imaging & Neurosciences Center
729 Arapeen Drive
Salt Lake City, UT 84108
Follow us on Facebook
Gordon J. Chelune, Ph.D., ABPP(CN)
Professor of Neurology
A Pioneer in Cognitive Testing
Dr. Chelune has dedicated his career to developing more accurate methods for cognitive testing, including detection of subtle cognitive difficulties associated with neurological illness. He has pioneered methods of assessing cognitive changes in patients following surgery, anesthesia and drug interventions. "Such tests can tell us whether the treatment really helped, or whether the patient's improved test performance simply reflects natural recovery or practice effects."
In recent years, Dr. Chelune's research has focused on methods to discern changes caused by Alzheimer's and similar diseases from changes that occur with normal aging. He is particularly interested in individual differences in disease progression and cognitive reserve.
"To be sure, there are important genetic, biological and environmental factors that account for differences in cognitive reserve," Dr. Chelune says. "Identifying and measuring these differences will help us to better counsel patients and their families and, ultimately, to find new ways to slow or even stop disease progression."
Dr. Chelune joined the University of Utah in 2006 as Professor in the Department of Neurology, where he is also the Senior Neuropsychologist for the Center for Alzheimer's Care, Imaging and Research (CACIR). He also is an active member of the University's Brain Institute, Center on Aging, and Department of Psychology. Dr. Chelune is a Fellow of the National Academy of Neuropsychology, American Psychological Association in the Division of Clinical Neuropsychology, and the Society for Personality Assessment. He has served as President of the National Academy of Neuropsychology and the Division of Clinical Neuropsychology of the American Psychological Association, and is currently the Executive Director of the International Neuropsychological Society.
Dr. Chelune earned his Ph.D. from the University of Nevada at Reno, and subsequently completed his neuropsychology fellowship at the University of Colorado Health Sciences Center. Before arriving in Utah, Dr. Chelune was a member of the Cleveland Clinic Foundation, where he was Director of Neuropsychological Services at the Mellen Center for Multiple Sclerosis Treatment and Research, and founder of the Section of Neuropsychology.
Dr. Chelune's research spans several areas but has focused primarily on longitudinal assessment and methods of measuring reliable change in outcomes research and cognitive aging, cognitive assessment methods, and memory disorders. He is currently developing methods for assessing trajectories of cognitive change over time as a potential biomarker of neurologic integrity for the early detection of dementia.
Click here to view Dr. Chelune's NIH Biosketch.
This Page Last Updated: August 17, 2015